| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998416 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
| 02/14/2006 | US6998405 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 02/14/2006 | US6998403 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
| 02/14/2006 | US6998383 Inhibitors of receptor activator of NF-κB and uses thereof |
| 02/14/2006 | US6998263 Methods of preparing and using a viral vector library |
| 02/14/2006 | CA2450740C Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/09/2006 | WO2006014572A1 Delivery system |
| 02/09/2006 | WO2006013873A1 Drugs having cyclooxygenase inhibiting activity |
| 02/09/2006 | WO2006000158A8 The use of laetispicine for manufacture of pharmaceutical composition |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030622 Compounds and methods for the treatment of urogenital disorders |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060030604 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 02/09/2006 | US20060030576 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030557 Substituted pyridines having antiangiogenic activity |
| 02/09/2006 | US20060030005 C3b/C4b complement receptor-like molecules and uses thereof |
| 02/09/2006 | DE102004032165A1 Use of plants of the genus Sideritis, their plant parts and/or their extracts for preventing and/or regulating disturbances with altered serotoninergic neurotransmission e.g. depression, pain, eating disorders and climacteric disturbance |
| 02/09/2006 | CA2572919A1 Delivery system |
| 02/09/2006 | CA2571377A1 Cyclic progestin regimens and kits |
| 02/08/2006 | EP1623984A1 Polymorphic form I of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/08/2006 | EP1623712A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues |
| 02/08/2006 | EP1623711A1 External patch containing estrogen and/or progestogen |
| 02/08/2006 | EP1623710A1 Receptor antagonist |
| 02/08/2006 | EP1623230A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 02/08/2006 | EP1622924A2 8$g(b)-vinyl-11$g(b)-( g(v)-substituted)alkyl-estra-1,3,5(10)-trienes |
| 02/08/2006 | EP1333858B1 Vaccines with enhanced immune response and methods for their preparation |
| 02/08/2006 | EP1237904B1 14,15-beta-methylene substituted androgens |
| 02/08/2006 | EP1235776B1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/08/2006 | EP1226176B1 Production of mammary secretion antibodies in farm animals |
| 02/08/2006 | EP1156822B1 Iin vitro method for synchronisation of oocyte maturation |
| 02/08/2006 | EP0948343B1 Alkyl peptide amides adapted for topical administration |
| 02/08/2006 | CN1732182A Peptides and medicinal compositions containing the same |
| 02/08/2006 | CN1730097A Pharmaceutical composition for preventing and curing endometritis and retained afterbirth disease of milk cow |
| 02/08/2006 | CN1730092A Chinese traditional medicine compound preparation for treating gynecologic inflammation and process for preparing the same |
| 02/08/2006 | CN1730073A Ovulation-promoting gestation-recovering pill |
| 02/08/2006 | CN1730060A Medicinal liquor for postpartum recuperation and preparation process thereof |
| 02/08/2006 | CN1730043A Gynecological inflammation diminishing powder and its preparing process |
| 02/08/2006 | CN1730038A Medicine for treating cystic hyperplasia of mammary gland and preparation method thereof |
| 02/08/2006 | CN1730011A Gynopathy treating soft capsule and preparing process thereof |
| 02/08/2006 | CN1730010A Chinese medicine preparation for treating gynecopathy and its preparation method |
| 02/08/2006 | CN1730000A Cervical erosion treating liquor |
| 02/08/2006 | CN1729994A Povidone iodine effervescence tablet for treating milk cow colpitis, its preparation process and application |
| 02/08/2006 | CN1729979A Soft capsule of fibrauretine composition |
| 02/08/2006 | CN1240836C Transforming growth factor alpha HI |
| 02/08/2006 | CN1240716C Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/08/2006 | CN1240419C Mastoplasia treating medicine and its preparation process |
| 02/08/2006 | CN1240414C Chinese proprietary medicine for improving function of female ovary as well as preparation method and application in pharmacy |
| 02/08/2006 | CN1240401C Preparation process of papaya for human and livestock to increase milk |
| 02/08/2006 | CN1240397C Process for preparing conjugated oestrogens from urine of pregnant mare |
| 02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
| 02/08/2006 | CN1240387C Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 02/08/2006 | CN1240375C Preparation of low dosage medicinal composition with uniform distribution and effect |
| 02/07/2006 | US6995297 diapers comprising pads made of mixtures of plant extracts and pulps; skin disorders |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995244 A mutant binding to prolactin receptor through site 1, does not bind through site 2 nor has diminished binding through site 2, and exhibits <1% of unmodified agonist activity; anticarcinogenic, -tumor and metastatis agents; breast/prostate cancer |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995161 Central nervous system disorders |
| 02/07/2006 | US6995159 4-piperazin-1-yl-2-(pyridin-2-ylmethoxy)-pyrimidine, 2-(6-methyl-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine, and 2-(6-chloro-pyridin-2-ylmethoxy)-4-piperazin-1-yl-pyrimidine; for treatment of seizure and eating disorders; reduced side effects |
| 02/07/2006 | US6995153 tachykinin receptor antagonist, in particular, an NK1 receptor antagonist; prophylactic or therapeutic agent against tachykinin receptor-related pathological conditions, including increased urinary frequency, incontinence, vomiting, inflammation |
| 02/07/2006 | US6995150 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 02/07/2006 | US6995149 Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994843 Delivery of stimulants through an inhalation route |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025334 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 02/02/2006 | US20060024290 prophylactic and/or therapeutic agent for the modification of fertility and behaviour patterns of animals, the achievement of livestock production gains such as increasing growth, decreasing feed conversion ratios or the control of unwanted organoleptic characteristics |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | CA2571347A1 Piperazine derivatives for the treatment of female sexual disorders |
| 02/01/2006 | EP1621549A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
| 02/01/2006 | EP1621198A2 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | EP0956040B1 Stimulation of host defense mechanisms against viral challenges |
| 02/01/2006 | EP0898478B1 Stimulation of host defence mechanisms against tumors |
| 02/01/2006 | CN1729185A Nobel compounds having selective inhibiting effect at GSK3 |
| 02/01/2006 | CN1728989A Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta. |
| 02/01/2006 | CN1727409A Composition of organosilicon, and controlled release rubberized tube for medication prepared from the composition |
| 02/01/2006 | CN1726991A Medication of treating by dysenorrhea, irregular menses, weakness after childbirth for women, and preparation method |
| 02/01/2006 | CN1726989A Medication for treating mastopathia, and preparation method |
| 02/01/2006 | CN1726985A Medication for treating chronic appendages inflammation, and preparation method |
| 02/01/2006 | CN1726976A Detergent in use for department of gynecology |
| 02/01/2006 | CN1726969A Small golden pellets and preparation method |
| 02/01/2006 | CN1726949A Ointment of Chinese traditional medicine for treating hyperplasia of mammary glands, and preparation method |
| 02/01/2006 | CN1726936A Formula of Chinese traditional medicine for treating mastitis and tuberculosis |
| 02/01/2006 | CN1726928A Combination of medication for treating hysteromycoma and preparation method |
| 02/01/2006 | CN1726927A Active function of ostrich blood |